Home688192 • SHA
add
Dizal Pharmaceutical Co Ltd
Previous close
¥48.64
Day range
¥47.60 - ¥52.70
Year range
¥42.40 - ¥86.18
Market cap
22.60B CNY
Avg Volume
2.28M
P/E ratio
-
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 214.83M | 901.58% |
Operating expense | 427.77M | 25.50% |
Net income | -183.36M | 36.22% |
Net profit margin | -85.35 | 93.63% |
Earnings per share | — | — |
EBITDA | -177.71M | 43.34% |
Effective tax rate | 1.71% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.93B | 129.32% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 1.44B | — |
Shares outstanding | 461.19M | — |
Price to book | 15.49 | — |
Return on assets | — | — |
Return on capital | -18.72% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -183.36M | 36.22% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
Oct 27, 2017
Website
Employees
985
